Dr. Jonathan Wingfield , Principal Scientist at AstraZeneca, discusses the development of acoustic mass spectrometry technology for high-throughput screening. Through the combination of acoustic technology from Labcyte and mass spectrometry systems from Waters, acoustic mass spectrometry provides rapid sample processing and analysis of a wide range of molecular targets, saving crucial time and reagents costs needed to screen millions of compounds within AstraZeneca’s small molecule and discovery programs.